Foton, Branislav ready for PSL’s biggest conference

first_imgCarpio hits red carpet treatment for China Coast Guard PLAY LIST 02:14Carpio hits red carpet treatment for China Coast Guard02:56NCRPO pledges to donate P3.5 million to victims of Taal eruption00:56Heavy rain brings some relief in Australia02:37Calm moments allow Taal folks some respite03:23Negosyo sa Tagaytay City, bagsak sa pag-aalboroto ng Bulkang Taal01:13Christian Standhardinger wins PBA Best Player award Foton will defend its title against eight other teams in the biggest Grand Prix to date.This season’s Grand Prix will feature nine teams—Foton, Petron, Cocolife, F2 Logistics, Generika, Sta. Lucia, Iriga, Cignal, and guest team University of Santo Tomas.Sports Related Videospowered by AdSparcRead Next MOST READ Iceland prepared for World Cup debut with 2 games in Qatar LATEST STORIES It’s too early to present Duterte’s ‘legacy’ – Lacson Judy Ann’s 1st project for 2020 is giving her a ‘stomachache’ Margot Robbie talks about filming ‘Bombshell’s’ disturbing sexual harassment scene Don’t miss out on the latest news and information. Jake says relationship with Shaina ‘goes beyond physical attraction’center_img OSG plea to revoke ABS-CBN franchise ‘a duplicitous move’ – Lacson The Tornadoes are shooting for their third straight title, but they have to do it without 2015 Grand Prix MVP Lindsay Stalzer, who was instrumental in their last two championships.Stalzer has jump shipped to Petron, the team Foton beat twice for the titles, in a move which Branislav respects.FEATURED STORIESSPORTSRedemption is sweet for Ginebra, Scottie ThompsonSPORTSMayweather beats Pacquiao, Canelo for ‘Fighter of the Decade’SPORTSFederer blasts lack of communication on Australian Open smog“We respect all players, and thanks to Lindsay because she played very hard last year for Foton.”Helping Branislav in his quest for a third straight Grand Prix title are Dragana Perunicnic, Sara Klisura, and libero Katarina Vukomanovic. Coaches Ramil de Jesus of F2 Logistics, Francis Vicente of Generika-Ayala, Parley Tupaz of Iriga City, George Pascua of Cignal, Moro Branislav of Foton, Shaq Delos Santos of Petron, John Paul Dolorias of UST, Kungfu Reyes of Cocolife and Macky Carino of Sta. Lucia declare readiness to compete in the Chooks To Go Philippine Superliga Grand Prix starting Saturday at Filoil Flying CentreFoton has been the ruler of the Philippine Superliga Grand Prix Conference and head coach Moro Branislav has been preparing his team to keep it that way this 2017.“My opinion is, Foton will bring a very big surprise this conference,” said Branislav Wednesday during the pre-season press conference atr Viking Venue. “I’ve been preparing my team and we’ll see how we’ll finish so good luck to all the other coaches.”ADVERTISEMENT Jo Koy: My brain always wants to think funny Jake says relationship with Shaina ‘goes beyond physical attraction’ Kiss-and-tell matinee idol’s conquests: True stories or tall tales? Coco’s house rules on ‘Probinsyano’ set View commentslast_img read more

The Lucrative Practice Of Flipping Drugs Buy The Rights Hike The Price

first_img In other pharmaceutical news — This is part of the KHN Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription. Dealmakers have always flipped companies. Lately, they’ve been flipping something else: aging pharmaceuticals. Take Actimmune, developed by Genentech Inc. decades ago. By 2012, sales were fizzling. Then rights to the immune-disorder treatment were acquired by a company backed by private equity. The price climbed, 434 percent in two years, and Actimmune was a hot property. Horizon Pharma Plc snapped it up. Or consider the old Novartis AG cold-sore cream Denavir, notching a 372 percent gain as it changed hands twice with private equity help. Or Dutoprol, 1,057 percent more expensive after a flip. Or Miacalcin, 3,259 percent higher. (Langreth, 11/2) The Wall Street Journal: Valeant, In Push For Cash, Looks To Sell Stomach-Drug Business Pfizer Inc. ended its bid to return to the multibillion-dollar cholesterol market that long fueled the company, halting development of a once-promising drug candidate amid safety concerns and mounting pricing pressures confronting the industry. (Rockoff and Hufford, 11/1) Reuters: Senator Grassley Asks Defense Department To Explain EpiPen Spending The Wall Street Journal: Pfizer Cuts Outlook, Ends Development Of Cholesterol Drug center_img For more news on high drug costs, check out our weekly feature, Prescription Drug Watch, which includes coverage and perspectives of the issue. The Lucrative Practice Of Flipping Drugs: Buy The Rights, Hike The Price, Then Resell Pharmaceutical companies seize on drugs with little competition, boost the price and then put it back up for sale. “They’re taking advantage of a dysfunctional market,” says Stephen Schondelmeyer, a professor of pharmaceutical economics. U.S. Senator Chuck Grassley asked the Department of Defense and the Department of Veterans Affairs on Tuesday to explain spending trends for the EpiPen emergency allergy treatment. The request followed a recent report by Reuters detailing how EpiPen price hikes by manufacturer Mylan NV had added millions to U.S. Department of Defense spending since 2008 as the agency covered more prescriptions for the lifesaving allergy shot at near retail prices. (Beasley, 11/1) Valeant Pharmaceuticals International Inc. is in advanced talks to sell a big stomach-drug business to Japan’s Takeda Pharmaceutical Co. for about $10 billion, a move seen easing pressure on Valeant over its hefty debt load. The companies could reach a deal for Salix Pharmaceuticals Ltd., which Valeant bought just a year-and-a-half ago for roughly $11 billion, in the coming weeks, people familiar with the matter said. (Benoit and Rockoff, 11/2) Bloomberg: Investors Are Hooked On Flipping Pharmaceuticals  last_img read more